-
From Fluorescence to Function in mRNA Delivery
2026-09-09
A thought-leadership guide to using dual-readout mRNA controls to connect particle delivery, intracellular localization, and protein expression. The article explains how ARCA capping and 5-methoxyuridine modification strengthen translational assay design while positioning fluorescence-based validation as a bridge to more predictive mRNA delivery systems.
-
mRNA Lipoplexes as Intravenous Tumour Vaccines
2026-09-09
Hattori and colleagues optimized PEGylation of cationic mRNA lipoplexes to reduce lung accumulation while preserving systemic tumour-vaccine activity. The resulting formulation generated strong anti-OVA antibody and cytotoxic responses and suppressed E.G7-OVA tumour growth in mice, highlighting how carrier composition can balance biodistribution and immunogenicity.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-08
Build a dual-readout assay that separates mRNA delivery from protein translation in mammalian cells. This workflow combines Cy5 tracking, EGFP expression, and carrier comparisons to improve mRNA delivery system research, including macrophage-focused studies.
-
Fluoroalkane Polymers for mRNA Cancer Vaccines
2026-09-08
The reference study developed fluoroalkane-grafted polyethylenimine as a simplified mRNA carrier that combines intracellular delivery with TLR4-associated immune stimulation. In mouse melanoma and colon cancer models, the resulting vaccines enhanced antigen presentation and produced antitumor activity, particularly when neoantigen vaccination was combined with immune checkpoint blockade.
-
HyperScript First-Strand cDNA Synthesis Kit Workflow
2026-09-07
Build a more resilient RNA-to-qPCR workflow for ovarian cancer research, including lncRNA, mRNA, and low-abundance transcript assays. Flexible primer selection and thermally stable reverse transcription help address structured RNA, limited input, and target-specific sensitivity challenges.
-
Ceruletide Workflows for Pancreatic Research
2026-09-07
Ceruletide, also known as Caerulein, provides a defined CCK-receptor stimulus for pancreatic secretion, acinar-cell stress, and gastrointestinal motility experiments. This practical guide connects controlled hormone-challenge workflows with emerging MFGE8-based antifibrotic research while emphasizing preparation, assay selection, and troubleshooting.
-
Methylprednisolone Workflows for Bone Inflammation
2026-09-05
Build reproducible inflammation and glucocorticoid-induced bone-injury models with Methylprednisolone, from macrophage cytokine assays to femoral-head imaging. The workflow pairs pathway-level measurements with osteoclast, vascular, histological, and micro-CT endpoints for stronger translational interpretation.
-
Topotecan: From Topo I Mechanism to Translation
2026-09-04
Topotecan, also known as SKF104864, is more than a cytotoxic screening reagent: it is a controllable perturbation of replication-associated DNA damage. This thought-leadership guide connects Topo I biology with assay design, combination strategy, ovarian cancer evidence, glioma research, and pediatric tumor translation.
-
Dual SMAD/Wnt Inhibition for iPSC-RGC Models
2026-09-04
The reference study presents a chemically defined, non-genetic strategy for directing induced pluripotent stem cells toward retinal ganglion cells through coordinated SMAD and canonical Wnt inhibition. Its reproducible yield and antibody-based enrichment address major bottlenecks in glaucoma modeling, while also providing a framework for evaluating RGC biology across iPSC lines.
-
Etoposide (VP-16) for DNA Damage Assays
2026-09-03
Etoposide (VP-16) provides a controllable way to induce topoisomerase II–linked DNA damage, apoptosis, and genome-stability phenotypes. This guide connects practical cell-based workflows with the nuclear cGAS–TRIM41–ORF2p findings of a recent reference study, while emphasizing dose selection, controls, and troubleshooting.
-
VE-822: From ATR Biology to Radiosensitizer Strategy
2026-09-03
VE-822 illustrates how selective ATR inhibition can convert replication stress into a therapeutic vulnerability, particularly when combined with radiation or gemcitabine in pancreatic cancer models. The next translational advantage will come from pairing compound potency with 2D, 3D, and context-aware experimental design.
-
Polygodial for TRPA1 Channel Assays
2026-09-02
Polygodial provides a practical chemical entry point for connecting TRPA1 activation with calcium dynamics, NFAT signaling, and inflammatory outputs. This guide translates epithelial-channel findings into controlled workflows for sensory neuron ion channel studies, neurophysiology research, and mechanistic assay troubleshooting.
-
PAD4-IN-2 TFA: Assay Design for Tumor Models
2026-09-02
PAD4-IN-2 TFA, also known as Compound 5i TFA, enables a tumor-targeted approach to studying PAD4, histone H3 citrullination, and NET biology. This guide focuses on assay architecture, orthogonal validation, and translational interpretation rather than repeating a general product overview.
-
Butylated Hydroxyanisole (BHA) in Redox Assays
2026-09-01
Butylated hydroxyanisole (BHA) is a practical redox perturbation tool for separating oxidative chemistry from assay artifacts. This guide shows how to prepare fresh solutions, design ROS and cell-protection controls, and translate peptide-receptor lessons into more reliable oxidative stress research.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-01
Use dual Cy5 and EGFP readouts to distinguish mRNA delivery from productive translation in mammalian cells. This workflow shows how to benchmark carriers, investigate macrophage uptake, and troubleshoot poor expression with a 5-methoxyuridine modified mRNA control.